nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—ADORA1—nerve—multiple sclerosis	0.0183	0.094	CbGeAlD
Pentoxifylline—NT5E—retina—multiple sclerosis	0.0123	0.0633	CbGeAlD
Pentoxifylline—NT5E—midbrain—multiple sclerosis	0.00815	0.0418	CbGeAlD
Pentoxifylline—PDE5A—retina—multiple sclerosis	0.00801	0.0411	CbGeAlD
Pentoxifylline—NT5E—spinal cord—multiple sclerosis	0.00795	0.0408	CbGeAlD
Pentoxifylline—NT5E—nervous system—multiple sclerosis	0.0067	0.0344	CbGeAlD
Pentoxifylline—NT5E—central nervous system—multiple sclerosis	0.00645	0.0331	CbGeAlD
Pentoxifylline—ADORA2B—nervous system—multiple sclerosis	0.00574	0.0294	CbGeAlD
Pentoxifylline—ADORA2A—spinal cord—multiple sclerosis	0.00567	0.0291	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—multiple sclerosis	0.00553	0.0283	CbGeAlD
Pentoxifylline—ADORA1—medulla oblongata—multiple sclerosis	0.00549	0.0281	CbGeAlD
Pentoxifylline—ADORA2B—cerebellum—multiple sclerosis	0.0054	0.0277	CbGeAlD
Pentoxifylline—NT5E—brain—multiple sclerosis	0.00512	0.0263	CbGeAlD
Pentoxifylline—ADORA1—midbrain—multiple sclerosis	0.00502	0.0257	CbGeAlD
Pentoxifylline—ADORA1—spinal cord—multiple sclerosis	0.00489	0.0251	CbGeAlD
Pentoxifylline—PDE4A—cerebellum—multiple sclerosis	0.00481	0.0247	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—multiple sclerosis	0.00478	0.0245	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—multiple sclerosis	0.0046	0.0236	CbGeAlD
Pentoxifylline—ADORA2A—cerebellum—multiple sclerosis	0.00449	0.023	CbGeAlD
Pentoxifylline—ADORA2B—brain—multiple sclerosis	0.00439	0.0225	CbGeAlD
Pentoxifylline—PDE5A—nervous system—multiple sclerosis	0.00435	0.0223	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—multiple sclerosis	0.00419	0.0215	CbGeAlD
Pentoxifylline—ADORA1—nervous system—multiple sclerosis	0.00412	0.0211	CbGeAlD
Pentoxifylline—PDE5A—cerebellum—multiple sclerosis	0.00409	0.021	CbGeAlD
Pentoxifylline—PDE4B—medulla oblongata—multiple sclerosis	0.00406	0.0208	CbGeAlD
Pentoxifylline—ADORA1—central nervous system—multiple sclerosis	0.00397	0.0203	CbGeAlD
Pentoxifylline—PDE4A—brain—multiple sclerosis	0.00391	0.02	CbGeAlD
Pentoxifylline—ADORA1—cerebellum—multiple sclerosis	0.00388	0.0199	CbGeAlD
Pentoxifylline—PDE4B—midbrain—multiple sclerosis	0.00371	0.019	CbGeAlD
Pentoxifylline—ADORA2A—brain—multiple sclerosis	0.00365	0.0187	CbGeAlD
Pentoxifylline—PDE4B—spinal cord—multiple sclerosis	0.00362	0.0186	CbGeAlD
Pentoxifylline—PDE5A—brain—multiple sclerosis	0.00332	0.017	CbGeAlD
Pentoxifylline—ADORA1—brain—multiple sclerosis	0.00315	0.0162	CbGeAlD
Pentoxifylline—PDE4B—nervous system—multiple sclerosis	0.00305	0.0156	CbGeAlD
Pentoxifylline—PDE4B—central nervous system—multiple sclerosis	0.00294	0.0151	CbGeAlD
Pentoxifylline—PDE4B—cerebellum—multiple sclerosis	0.00287	0.0147	CbGeAlD
Pentoxifylline—PDE4B—brain—multiple sclerosis	0.00233	0.0119	CbGeAlD
Pentoxifylline—Convulsion—Methylprednisolone—multiple sclerosis	0.000916	0.00165	CcSEcCtD
Pentoxifylline—Hypertension—Triamcinolone—multiple sclerosis	0.000915	0.00165	CcSEcCtD
Pentoxifylline—Hypertension—Methylprednisolone—multiple sclerosis	0.000913	0.00164	CcSEcCtD
Pentoxifylline—Urticaria—Mitoxantrone—multiple sclerosis	0.000911	0.00164	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000909	0.00164	CcSEcCtD
Pentoxifylline—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000906	0.00163	CcSEcCtD
Pentoxifylline—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000906	0.00163	CcSEcCtD
Pentoxifylline—Myalgia—Triamcinolone—multiple sclerosis	0.000902	0.00162	CcSEcCtD
Pentoxifylline—Vomiting—Azathioprine—multiple sclerosis	0.000902	0.00162	CcSEcCtD
Pentoxifylline—Myalgia—Methylprednisolone—multiple sclerosis	0.0009	0.00162	CcSEcCtD
Pentoxifylline—Anxiety—Methylprednisolone—multiple sclerosis	0.000897	0.00161	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—multiple sclerosis	0.000896	0.00161	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—multiple sclerosis	0.000896	0.00161	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—multiple sclerosis	0.000896	0.00161	CcSEcCtD
Pentoxifylline—Rash—Azathioprine—multiple sclerosis	0.000894	0.00161	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000894	0.00161	CcSEcCtD
Pentoxifylline—Dermatitis—Azathioprine—multiple sclerosis	0.000894	0.00161	CcSEcCtD
Pentoxifylline—Flushing—Prednisone—multiple sclerosis	0.000893	0.00161	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000892	0.0016	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000892	0.0016	CcSEcCtD
Pentoxifylline—Discomfort—Triamcinolone—multiple sclerosis	0.000892	0.0016	CcSEcCtD
Pentoxifylline—Discomfort—Methylprednisolone—multiple sclerosis	0.00089	0.0016	CcSEcCtD
Pentoxifylline—Headache—Azathioprine—multiple sclerosis	0.000889	0.0016	CcSEcCtD
Pentoxifylline—Dry mouth—Triamcinolone—multiple sclerosis	0.000883	0.00159	CcSEcCtD
Pentoxifylline—Angioedema—Dexamethasone—multiple sclerosis	0.000879	0.00158	CcSEcCtD
Pentoxifylline—Angioedema—Betamethasone—multiple sclerosis	0.000879	0.00158	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—multiple sclerosis	0.000871	0.00157	CcSEcCtD
Pentoxifylline—Confusional state—Methylprednisolone—multiple sclerosis	0.00087	0.00156	CcSEcCtD
Pentoxifylline—Immune system disorder—Prednisone—multiple sclerosis	0.000869	0.00156	CcSEcCtD
Pentoxifylline—Malaise—Betamethasone—multiple sclerosis	0.000867	0.00156	CcSEcCtD
Pentoxifylline—Malaise—Dexamethasone—multiple sclerosis	0.000867	0.00156	CcSEcCtD
Pentoxifylline—Oedema—Triamcinolone—multiple sclerosis	0.000865	0.00156	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000865	0.00156	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000863	0.00155	CcSEcCtD
Pentoxifylline—Arrhythmia—Prednisone—multiple sclerosis	0.00086	0.00155	CcSEcCtD
Pentoxifylline—Infection—Triamcinolone—multiple sclerosis	0.000859	0.00155	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—multiple sclerosis	0.000859	0.00154	CcSEcCtD
Pentoxifylline—Infection—Methylprednisolone—multiple sclerosis	0.000858	0.00154	CcSEcCtD
Pentoxifylline—Shock—Triamcinolone—multiple sclerosis	0.000851	0.00153	CcSEcCtD
Pentoxifylline—Insomnia—Prednisolone—multiple sclerosis	0.000851	0.00153	CcSEcCtD
Pentoxifylline—Shock—Methylprednisolone—multiple sclerosis	0.000849	0.00153	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000847	0.00152	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—multiple sclerosis	0.000845	0.00152	CcSEcCtD
Pentoxifylline—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000845	0.00152	CcSEcCtD
Pentoxifylline—Tachycardia—Triamcinolone—multiple sclerosis	0.000844	0.00152	CcSEcCtD
Pentoxifylline—Nausea—Azathioprine—multiple sclerosis	0.000843	0.00151	CcSEcCtD
Pentoxifylline—Tachycardia—Methylprednisolone—multiple sclerosis	0.000842	0.00151	CcSEcCtD
Pentoxifylline—Skin disorder—Methylprednisolone—multiple sclerosis	0.000838	0.00151	CcSEcCtD
Pentoxifylline—Erythema—Prednisone—multiple sclerosis	0.000838	0.00151	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000836	0.0015	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000834	0.0015	CcSEcCtD
Pentoxifylline—Convulsion—Betamethasone—multiple sclerosis	0.000833	0.0015	CcSEcCtD
Pentoxifylline—Convulsion—Dexamethasone—multiple sclerosis	0.000833	0.0015	CcSEcCtD
Pentoxifylline—Hypertension—Dexamethasone—multiple sclerosis	0.00083	0.00149	CcSEcCtD
Pentoxifylline—Hypertension—Betamethasone—multiple sclerosis	0.00083	0.00149	CcSEcCtD
Pentoxifylline—Asthenia—Mitoxantrone—multiple sclerosis	0.000823	0.00148	CcSEcCtD
Pentoxifylline—Myalgia—Dexamethasone—multiple sclerosis	0.000819	0.00147	CcSEcCtD
Pentoxifylline—Myalgia—Betamethasone—multiple sclerosis	0.000819	0.00147	CcSEcCtD
Pentoxifylline—Anxiety—Betamethasone—multiple sclerosis	0.000816	0.00147	CcSEcCtD
Pentoxifylline—Anxiety—Dexamethasone—multiple sclerosis	0.000816	0.00147	CcSEcCtD
Pentoxifylline—Discomfort—Dexamethasone—multiple sclerosis	0.000809	0.00145	CcSEcCtD
Pentoxifylline—Discomfort—Betamethasone—multiple sclerosis	0.000809	0.00145	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—multiple sclerosis	0.000808	0.00145	CcSEcCtD
Pentoxifylline—Hypotension—Methylprednisolone—multiple sclerosis	0.000807	0.00145	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—multiple sclerosis	0.000804	0.00145	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—multiple sclerosis	0.000804	0.00145	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisone—multiple sclerosis	0.000789	0.00142	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000788	0.00142	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000786	0.00141	CcSEcCtD
Pentoxifylline—Oedema—Dexamethasone—multiple sclerosis	0.000785	0.00141	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000785	0.00141	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000785	0.00141	CcSEcCtD
Pentoxifylline—Oedema—Betamethasone—multiple sclerosis	0.000785	0.00141	CcSEcCtD
Pentoxifylline—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000785	0.00141	CcSEcCtD
Pentoxifylline—Insomnia—Triamcinolone—multiple sclerosis	0.000782	0.00141	CcSEcCtD
Pentoxifylline—Insomnia—Methylprednisolone—multiple sclerosis	0.000781	0.0014	CcSEcCtD
Pentoxifylline—Infection—Dexamethasone—multiple sclerosis	0.00078	0.0014	CcSEcCtD
Pentoxifylline—Infection—Betamethasone—multiple sclerosis	0.00078	0.0014	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisone—multiple sclerosis	0.000777	0.0014	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisolone—multiple sclerosis	0.000775	0.00139	CcSEcCtD
Pentoxifylline—Anaemia—Prednisone—multiple sclerosis	0.000774	0.00139	CcSEcCtD
Pentoxifylline—Shock—Betamethasone—multiple sclerosis	0.000772	0.00139	CcSEcCtD
Pentoxifylline—Shock—Dexamethasone—multiple sclerosis	0.000772	0.00139	CcSEcCtD
Pentoxifylline—Dyspnoea—Triamcinolone—multiple sclerosis	0.000771	0.00139	CcSEcCtD
Pentoxifylline—Agitation—Prednisone—multiple sclerosis	0.00077	0.00138	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000769	0.00138	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000769	0.00138	CcSEcCtD
Pentoxifylline—Tachycardia—Betamethasone—multiple sclerosis	0.000766	0.00138	CcSEcCtD
Pentoxifylline—Tachycardia—Dexamethasone—multiple sclerosis	0.000766	0.00138	CcSEcCtD
Pentoxifylline—Angioedema—Prednisone—multiple sclerosis	0.000765	0.00138	CcSEcCtD
Pentoxifylline—Dyspepsia—Triamcinolone—multiple sclerosis	0.000762	0.00137	CcSEcCtD
Pentoxifylline—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00076	0.00137	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000759	0.00136	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000759	0.00136	CcSEcCtD
Pentoxifylline—Malaise—Prednisone—multiple sclerosis	0.000755	0.00136	CcSEcCtD
Pentoxifylline—Anorexia—Dexamethasone—multiple sclerosis	0.000748	0.00135	CcSEcCtD
Pentoxifylline—Anorexia—Betamethasone—multiple sclerosis	0.000748	0.00135	CcSEcCtD
Pentoxifylline—Urticaria—Prednisolone—multiple sclerosis	0.000747	0.00134	CcSEcCtD
Pentoxifylline—Hypotension—Betamethasone—multiple sclerosis	0.000734	0.00132	CcSEcCtD
Pentoxifylline—Hypotension—Dexamethasone—multiple sclerosis	0.000734	0.00132	CcSEcCtD
Pentoxifylline—Vomiting—Mitoxantrone—multiple sclerosis	0.000729	0.00131	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—multiple sclerosis	0.000726	0.00131	CcSEcCtD
Pentoxifylline—Convulsion—Prednisone—multiple sclerosis	0.000726	0.0013	CcSEcCtD
Pentoxifylline—Hypertension—Prednisone—multiple sclerosis	0.000723	0.0013	CcSEcCtD
Pentoxifylline—Rash—Mitoxantrone—multiple sclerosis	0.000723	0.0013	CcSEcCtD
Pentoxifylline—Dermatitis—Mitoxantrone—multiple sclerosis	0.000722	0.0013	CcSEcCtD
Pentoxifylline—Headache—Mitoxantrone—multiple sclerosis	0.000718	0.00129	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000715	0.00129	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000715	0.00129	CcSEcCtD
Pentoxifylline—Myalgia—Prednisone—multiple sclerosis	0.000713	0.00128	CcSEcCtD
Pentoxifylline—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000713	0.00128	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000711	0.00128	CcSEcCtD
Pentoxifylline—Anxiety—Prednisone—multiple sclerosis	0.000711	0.00128	CcSEcCtD
Pentoxifylline—Insomnia—Betamethasone—multiple sclerosis	0.00071	0.00128	CcSEcCtD
Pentoxifylline—Insomnia—Dexamethasone—multiple sclerosis	0.00071	0.00128	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000708	0.00127	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000706	0.00127	CcSEcCtD
Pentoxifylline—Discomfort—Prednisone—multiple sclerosis	0.000705	0.00127	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—multiple sclerosis	0.0007	0.00126	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisolone—multiple sclerosis	0.000693	0.00125	CcSEcCtD
Pentoxifylline—Dyspepsia—Betamethasone—multiple sclerosis	0.000691	0.00124	CcSEcCtD
Pentoxifylline—Dyspepsia—Dexamethasone—multiple sclerosis	0.000691	0.00124	CcSEcCtD
Pentoxifylline—Urticaria—Triamcinolone—multiple sclerosis	0.000687	0.00124	CcSEcCtD
Pentoxifylline—Urticaria—Methylprednisolone—multiple sclerosis	0.000686	0.00123	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—multiple sclerosis	0.000686	0.00123	CcSEcCtD
Pentoxifylline—Body temperature increased—Triamcinolone—multiple sclerosis	0.000684	0.00123	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisone—multiple sclerosis	0.000684	0.00123	CcSEcCtD
Pentoxifylline—Oedema—Prednisone—multiple sclerosis	0.000684	0.00123	CcSEcCtD
Pentoxifylline—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000682	0.00123	CcSEcCtD
Pentoxifylline—Decreased appetite—Betamethasone—multiple sclerosis	0.000682	0.00123	CcSEcCtD
Pentoxifylline—Decreased appetite—Dexamethasone—multiple sclerosis	0.000682	0.00123	CcSEcCtD
Pentoxifylline—Nausea—Mitoxantrone—multiple sclerosis	0.000681	0.00122	CcSEcCtD
Pentoxifylline—Infection—Prednisone—multiple sclerosis	0.000679	0.00122	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—multiple sclerosis	0.000677	0.00122	CcSEcCtD
Pentoxifylline—Shock—Prednisone—multiple sclerosis	0.000673	0.00121	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisone—multiple sclerosis	0.000667	0.0012	CcSEcCtD
Pentoxifylline—Skin disorder—Prednisone—multiple sclerosis	0.000664	0.00119	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisone—multiple sclerosis	0.000661	0.00119	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—multiple sclerosis	0.00066	0.00119	CcSEcCtD
Pentoxifylline—Anorexia—Prednisone—multiple sclerosis	0.000652	0.00117	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00065	0.00117	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—multiple sclerosis	0.000647	0.00116	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000647	0.00116	CcSEcCtD
Pentoxifylline—Feeling abnormal—Betamethasone—multiple sclerosis	0.000647	0.00116	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000642	0.00115	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000642	0.00115	CcSEcCtD
Pentoxifylline—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000637	0.00115	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000636	0.00114	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—multiple sclerosis	0.000631	0.00114	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—multiple sclerosis	0.000627	0.00113	CcSEcCtD
Pentoxifylline—Urticaria—Dexamethasone—multiple sclerosis	0.000624	0.00112	CcSEcCtD
Pentoxifylline—Urticaria—Betamethasone—multiple sclerosis	0.000624	0.00112	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000623	0.00112	CcSEcCtD
Pentoxifylline—Dizziness—Prednisolone—multiple sclerosis	0.000622	0.00112	CcSEcCtD
Pentoxifylline—Asthenia—Triamcinolone—multiple sclerosis	0.000621	0.00112	CcSEcCtD
Pentoxifylline—Abdominal pain—Dexamethasone—multiple sclerosis	0.000621	0.00112	CcSEcCtD
Pentoxifylline—Body temperature increased—Betamethasone—multiple sclerosis	0.000621	0.00112	CcSEcCtD
Pentoxifylline—Abdominal pain—Betamethasone—multiple sclerosis	0.000621	0.00112	CcSEcCtD
Pentoxifylline—Body temperature increased—Dexamethasone—multiple sclerosis	0.000621	0.00112	CcSEcCtD
Pentoxifylline—Asthenia—Methylprednisolone—multiple sclerosis	0.000619	0.00111	CcSEcCtD
Pentoxifylline—Insomnia—Prednisone—multiple sclerosis	0.000618	0.00111	CcSEcCtD
Pentoxifylline—Pruritus—Triamcinolone—multiple sclerosis	0.000612	0.0011	CcSEcCtD
Pentoxifylline—Pruritus—Methylprednisolone—multiple sclerosis	0.000611	0.0011	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—multiple sclerosis	0.000607	0.00109	CcSEcCtD
Pentoxifylline—Dyspepsia—Prednisone—multiple sclerosis	0.000602	0.00108	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—multiple sclerosis	0.000596	0.00107	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—multiple sclerosis	0.000596	0.00107	CcSEcCtD
Pentoxifylline—Decreased appetite—Prednisone—multiple sclerosis	0.000594	0.00107	CcSEcCtD
Pentoxifylline—Rash—Prednisolone—multiple sclerosis	0.000593	0.00107	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisolone—multiple sclerosis	0.000593	0.00107	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000592	0.00106	CcSEcCtD
Pentoxifylline—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000591	0.00106	CcSEcCtD
Pentoxifylline—Headache—Prednisolone—multiple sclerosis	0.000589	0.00106	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—multiple sclerosis	0.000589	0.00106	CcSEcCtD
Pentoxifylline—Constipation—Prednisone—multiple sclerosis	0.000585	0.00105	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—multiple sclerosis	0.000576	0.00104	CcSEcCtD
Pentoxifylline—Dizziness—Triamcinolone—multiple sclerosis	0.000572	0.00103	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000571	0.00103	CcSEcCtD
Pentoxifylline—Dizziness—Methylprednisolone—multiple sclerosis	0.000571	0.00103	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—multiple sclerosis	0.000568	0.00102	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisone—multiple sclerosis	0.000563	0.00101	CcSEcCtD
Pentoxifylline—Asthenia—Betamethasone—multiple sclerosis	0.000563	0.00101	CcSEcCtD
Pentoxifylline—Asthenia—Dexamethasone—multiple sclerosis	0.000563	0.00101	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000559	0.00101	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000559	0.00101	CcSEcCtD
Pentoxifylline—Nausea—Prednisolone—multiple sclerosis	0.000559	0.001	CcSEcCtD
Pentoxifylline—Pruritus—Betamethasone—multiple sclerosis	0.000555	0.000999	CcSEcCtD
Pentoxifylline—Pruritus—Dexamethasone—multiple sclerosis	0.000555	0.000999	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—multiple sclerosis	0.000555	0.000998	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000552	0.000993	CcSEcCtD
Pentoxifylline—Vomiting—Triamcinolone—multiple sclerosis	0.00055	0.000989	CcSEcCtD
Pentoxifylline—Vomiting—Methylprednisolone—multiple sclerosis	0.000549	0.000987	CcSEcCtD
Pentoxifylline—Rash—Triamcinolone—multiple sclerosis	0.000545	0.000981	CcSEcCtD
Pentoxifylline—Dermatitis—Triamcinolone—multiple sclerosis	0.000545	0.00098	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—multiple sclerosis	0.000545	0.000979	CcSEcCtD
Pentoxifylline—Rash—Methylprednisolone—multiple sclerosis	0.000544	0.000979	CcSEcCtD
Pentoxifylline—Dermatitis—Methylprednisolone—multiple sclerosis	0.000544	0.000978	CcSEcCtD
Pentoxifylline—Urticaria—Prednisone—multiple sclerosis	0.000543	0.000976	CcSEcCtD
Pentoxifylline—Headache—Triamcinolone—multiple sclerosis	0.000542	0.000974	CcSEcCtD
Pentoxifylline—Headache—Methylprednisolone—multiple sclerosis	0.000541	0.000972	CcSEcCtD
Pentoxifylline—Body temperature increased—Prednisone—multiple sclerosis	0.00054	0.000972	CcSEcCtD
Pentoxifylline—Abdominal pain—Prednisone—multiple sclerosis	0.00054	0.000972	CcSEcCtD
Pentoxifylline—Diarrhoea—Betamethasone—multiple sclerosis	0.000537	0.000966	CcSEcCtD
Pentoxifylline—Diarrhoea—Dexamethasone—multiple sclerosis	0.000537	0.000966	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—multiple sclerosis	0.000534	0.00096	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000521	0.000936	CcSEcCtD
Pentoxifylline—Dizziness—Dexamethasone—multiple sclerosis	0.000519	0.000933	CcSEcCtD
Pentoxifylline—Dizziness—Betamethasone—multiple sclerosis	0.000519	0.000933	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—multiple sclerosis	0.000517	0.000929	CcSEcCtD
Pentoxifylline—Nausea—Triamcinolone—multiple sclerosis	0.000514	0.000924	CcSEcCtD
Pentoxifylline—Nausea—Methylprednisolone—multiple sclerosis	0.000513	0.000922	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—multiple sclerosis	0.000509	0.000916	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—multiple sclerosis	0.000508	0.000913	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisone—multiple sclerosis	0.000504	0.000906	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—multiple sclerosis	0.000503	0.000904	CcSEcCtD
Pentoxifylline—Vomiting—Dexamethasone—multiple sclerosis	0.000499	0.000897	CcSEcCtD
Pentoxifylline—Vomiting—Betamethasone—multiple sclerosis	0.000499	0.000897	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—multiple sclerosis	0.000497	0.000893	CcSEcCtD
Pentoxifylline—Rash—Dexamethasone—multiple sclerosis	0.000495	0.00089	CcSEcCtD
Pentoxifylline—Rash—Betamethasone—multiple sclerosis	0.000495	0.00089	CcSEcCtD
Pentoxifylline—Dermatitis—Betamethasone—multiple sclerosis	0.000494	0.000889	CcSEcCtD
Pentoxifylline—Dermatitis—Dexamethasone—multiple sclerosis	0.000494	0.000889	CcSEcCtD
Pentoxifylline—Headache—Dexamethasone—multiple sclerosis	0.000492	0.000884	CcSEcCtD
Pentoxifylline—Headache—Betamethasone—multiple sclerosis	0.000492	0.000884	CcSEcCtD
Pentoxifylline—Asthenia—Prednisone—multiple sclerosis	0.00049	0.000882	CcSEcCtD
Pentoxifylline—Pruritus—Prednisone—multiple sclerosis	0.000484	0.00087	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—multiple sclerosis	0.000471	0.000847	CcSEcCtD
Pentoxifylline—Diarrhoea—Prednisone—multiple sclerosis	0.000468	0.000841	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000467	0.00084	CcSEcCtD
Pentoxifylline—Nausea—Dexamethasone—multiple sclerosis	0.000466	0.000838	CcSEcCtD
Pentoxifylline—Nausea—Betamethasone—multiple sclerosis	0.000466	0.000838	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—multiple sclerosis	0.000454	0.000816	CcSEcCtD
Pentoxifylline—Dizziness—Prednisone—multiple sclerosis	0.000452	0.000813	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—multiple sclerosis	0.000452	0.000812	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—multiple sclerosis	0.000452	0.000812	CcSEcCtD
Pentoxifylline—Vomiting—Prednisone—multiple sclerosis	0.000435	0.000782	CcSEcCtD
Pentoxifylline—Rash—Prednisone—multiple sclerosis	0.000431	0.000775	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisone—multiple sclerosis	0.000431	0.000774	CcSEcCtD
Pentoxifylline—Headache—Prednisone—multiple sclerosis	0.000428	0.00077	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—multiple sclerosis	0.000421	0.000757	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—multiple sclerosis	0.00041	0.000737	CcSEcCtD
Pentoxifylline—Nausea—Prednisone—multiple sclerosis	0.000406	0.00073	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—multiple sclerosis	0.000404	0.000727	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—multiple sclerosis	0.000391	0.000703	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—multiple sclerosis	0.000378	0.000679	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—multiple sclerosis	0.000363	0.000653	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—multiple sclerosis	0.00036	0.000648	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—multiple sclerosis	0.00036	0.000647	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—multiple sclerosis	0.000358	0.000644	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—multiple sclerosis	0.000339	0.00061	CcSEcCtD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL13—multiple sclerosis	0.000248	0.000999	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000248	0.000998	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000248	0.000997	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TGFB1—multiple sclerosis	0.000245	0.000983	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000243	0.000978	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—MAPK1—multiple sclerosis	0.00024	0.000964	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00024	0.000964	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	0.000237	0.000954	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL3—multiple sclerosis	0.000234	0.000941	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000233	0.000937	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCL5—multiple sclerosis	0.000231	0.000927	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000231	0.000927	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00023	0.000925	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000229	0.00092	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000228	0.000916	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—POMC—multiple sclerosis	0.000227	0.000912	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000226	0.000907	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000225	0.000906	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000225	0.000905	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RGS1—multiple sclerosis	0.000224	0.0009	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—multiple sclerosis	0.000219	0.00088	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000218	0.000875	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000216	0.000868	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	0.000216	0.000867	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000215	0.000865	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000213	0.000858	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GPR65—multiple sclerosis	0.000212	0.000853	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR2—multiple sclerosis	0.000212	0.000851	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL3—multiple sclerosis	0.000211	0.000847	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCL5—multiple sclerosis	0.000209	0.000842	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000209	0.000839	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000209	0.000839	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCR5—multiple sclerosis	0.000208	0.000836	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000208	0.000836	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—POMC—multiple sclerosis	0.000208	0.000835	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ALB—multiple sclerosis	0.000207	0.000832	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000205	0.000823	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000205	0.000823	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CCL2—multiple sclerosis	0.000203	0.000817	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000203	0.000816	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTGER4—multiple sclerosis	0.000203	0.000815	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000203	0.000814	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PGR—multiple sclerosis	0.0002	0.000803	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000199	0.000798	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL5—multiple sclerosis	0.000196	0.000789	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCR3—multiple sclerosis	0.000196	0.000787	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CNR1—multiple sclerosis	0.000195	0.000786	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000195	0.000782	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL13—multiple sclerosis	0.000194	0.00078	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR1—multiple sclerosis	0.000194	0.00078	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CD28—multiple sclerosis	0.000194	0.00078	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL5—multiple sclerosis	0.000194	0.000779	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000194	0.000779	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000192	0.000773	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000192	0.000771	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL3—multiple sclerosis	0.000191	0.000769	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR2—multiple sclerosis	0.000191	0.000766	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00019	0.000762	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000189	0.00076	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000189	0.00076	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCR5—multiple sclerosis	0.000189	0.000759	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000186	0.000748	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTGER4—multiple sclerosis	0.000184	0.00074	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—STAT3—multiple sclerosis	0.000182	0.000734	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PGR—multiple sclerosis	0.000181	0.000729	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL3—multiple sclerosis	0.000179	0.00072	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—POMC—multiple sclerosis	0.000179	0.000719	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCR3—multiple sclerosis	0.000178	0.000715	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL3—multiple sclerosis	0.000177	0.000712	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCR5—multiple sclerosis	0.000177	0.00071	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CD28—multiple sclerosis	0.000176	0.000708	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000176	0.000707	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CNR1—multiple sclerosis	0.000176	0.000707	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCR5—multiple sclerosis	0.000175	0.000702	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000174	0.0007	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR2—multiple sclerosis	0.000173	0.000696	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTGER4—multiple sclerosis	0.000172	0.000693	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000172	0.000692	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTGER4—multiple sclerosis	0.00017	0.000685	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PGR—multiple sclerosis	0.00017	0.000683	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—multiple sclerosis	0.000169	0.000679	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PGR—multiple sclerosis	0.000168	0.000675	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000167	0.00067	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCR3—multiple sclerosis	0.000167	0.00067	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—MAPK1—multiple sclerosis	0.000166	0.000667	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	0.000166	0.000666	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CD28—multiple sclerosis	0.000165	0.000663	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCR3—multiple sclerosis	0.000165	0.000662	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CD28—multiple sclerosis	0.000163	0.000655	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—POMC—multiple sclerosis	0.000162	0.000653	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—POMC—multiple sclerosis	0.000162	0.000653	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR2—multiple sclerosis	0.000162	0.000651	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR2—multiple sclerosis	0.00016	0.000644	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CNR1—multiple sclerosis	0.00016	0.000642	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCL2—multiple sclerosis	0.000159	0.000639	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL10—multiple sclerosis	0.000158	0.000636	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—POMC—multiple sclerosis	0.000152	0.000611	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL5—multiple sclerosis	0.000151	0.000609	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—POMC—multiple sclerosis	0.00015	0.000604	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR5—multiple sclerosis	0.00015	0.000604	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CNR1—multiple sclerosis	0.00015	0.000601	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000148	0.000595	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CNR1—multiple sclerosis	0.000148	0.000594	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—POMC—multiple sclerosis	0.000147	0.000593	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCL2—multiple sclerosis	0.000144	0.00058	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TYK2—multiple sclerosis	0.000144	0.00058	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL10—multiple sclerosis	0.000144	0.000578	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CD86—multiple sclerosis	0.000138	0.000557	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL3—multiple sclerosis	0.000138	0.000556	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—POMC—multiple sclerosis	0.000138	0.000555	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—POMC—multiple sclerosis	0.000136	0.000549	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR5—multiple sclerosis	0.000136	0.000549	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL5—multiple sclerosis	0.000136	0.000548	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL2—multiple sclerosis	0.000135	0.000543	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL10—multiple sclerosis	0.000135	0.000541	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000134	0.000541	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL2—multiple sclerosis	0.000134	0.000537	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTGER4—multiple sclerosis	0.000133	0.000535	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL10—multiple sclerosis	0.000133	0.000535	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2—multiple sclerosis	0.000132	0.000532	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SRM—multiple sclerosis	0.000132	0.00053	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PGR—multiple sclerosis	0.000131	0.000527	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TYK2—multiple sclerosis	0.000131	0.000527	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCR3—multiple sclerosis	0.000129	0.000517	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—multiple sclerosis	0.000127	0.000512	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CD28—multiple sclerosis	0.000127	0.000512	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SPP1—multiple sclerosis	0.000126	0.000507	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CD86—multiple sclerosis	0.000126	0.000505	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR2—multiple sclerosis	0.000125	0.000503	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL5—multiple sclerosis	0.000124	0.000498	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR5—multiple sclerosis	0.000123	0.000494	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TYK2—multiple sclerosis	0.000123	0.000493	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—POMC—multiple sclerosis	0.000122	0.000492	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TYK2—multiple sclerosis	0.000121	0.000487	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2RA—multiple sclerosis	0.000121	0.000486	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2—multiple sclerosis	0.00012	0.000483	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2—multiple sclerosis	0.00012	0.000483	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CD86—multiple sclerosis	0.000118	0.000473	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—POMC—multiple sclerosis	0.000117	0.000472	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CD86—multiple sclerosis	0.000116	0.000468	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL5—multiple sclerosis	0.000116	0.000466	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CNR1—multiple sclerosis	0.000115	0.000464	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SPP1—multiple sclerosis	0.000115	0.000461	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL5—multiple sclerosis	0.000114	0.00046	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2—multiple sclerosis	0.000112	0.000452	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOE—multiple sclerosis	0.000112	0.000449	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR5—multiple sclerosis	0.000111	0.000448	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2—multiple sclerosis	0.000111	0.000447	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2RA—multiple sclerosis	0.00011	0.000442	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—multiple sclerosis	0.000109	0.000438	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SPP1—multiple sclerosis	0.000107	0.000431	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—POMC—multiple sclerosis	0.000107	0.000429	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SPP1—multiple sclerosis	0.000106	0.000426	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR5—multiple sclerosis	0.000104	0.00042	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL2—multiple sclerosis	0.000104	0.000419	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL10—multiple sclerosis	0.000104	0.000418	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR5—multiple sclerosis	0.000103	0.000415	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2RA—multiple sclerosis	0.000103	0.000414	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—multiple sclerosis	0.000102	0.00041	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2RA—multiple sclerosis	0.000102	0.000409	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOE—multiple sclerosis	0.000101	0.000408	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CD80—multiple sclerosis	0.000101	0.000406	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—multiple sclerosis	0.000101	0.000406	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—POMC—multiple sclerosis	9.6e-05	0.000386	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOE—multiple sclerosis	9.5e-05	0.000382	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TYK2—multiple sclerosis	9.47e-05	0.000381	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL2—multiple sclerosis	9.39e-05	0.000377	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOE—multiple sclerosis	9.38e-05	0.000377	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	9.29e-05	0.000374	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	9.29e-05	0.000374	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAPK1—multiple sclerosis	9.19e-05	0.000369	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CD80—multiple sclerosis	9.17e-05	0.000369	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CD86—multiple sclerosis	9.09e-05	0.000365	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.08e-05	0.000365	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL5—multiple sclerosis	8.95e-05	0.00036	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—POMC—multiple sclerosis	8.71e-05	0.00035	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—multiple sclerosis	8.68e-05	0.000349	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CD80—multiple sclerosis	8.59e-05	0.000345	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TYK2—multiple sclerosis	8.53e-05	0.000343	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL2—multiple sclerosis	8.53e-05	0.000343	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPC5—multiple sclerosis	8.5e-05	0.000342	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CD80—multiple sclerosis	8.48e-05	0.000341	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAPK1—multiple sclerosis	8.34e-05	0.000335	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SPP1—multiple sclerosis	8.29e-05	0.000333	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—POMC—multiple sclerosis	8.16e-05	0.000328	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—POMC—multiple sclerosis	8.06e-05	0.000324	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR5—multiple sclerosis	8.06e-05	0.000324	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL2—multiple sclerosis	7.98e-05	0.000321	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2RA—multiple sclerosis	7.94e-05	0.000319	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL2—multiple sclerosis	7.89e-05	0.000317	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—multiple sclerosis	7.88e-05	0.000317	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAPK1—multiple sclerosis	7.81e-05	0.000314	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TYK2—multiple sclerosis	7.74e-05	0.000311	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAPK1—multiple sclerosis	7.72e-05	0.00031	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOE—multiple sclerosis	7.33e-05	0.000295	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TYK2—multiple sclerosis	7.25e-05	0.000291	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TYK2—multiple sclerosis	7.16e-05	0.000288	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—multiple sclerosis	7.09e-05	0.000285	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—multiple sclerosis	7.06e-05	0.000284	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RRM1—multiple sclerosis	7.04e-05	0.000283	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—multiple sclerosis	6.71e-05	0.00027	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CD80—multiple sclerosis	6.63e-05	0.000267	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—multiple sclerosis	6.44e-05	0.000259	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—multiple sclerosis	6.41e-05	0.000258	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—POMC—multiple sclerosis	6.3e-05	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL2—multiple sclerosis	6.16e-05	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—multiple sclerosis	6.1e-05	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—multiple sclerosis	6.03e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.03e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—multiple sclerosis	6e-05	0.000241	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—multiple sclerosis	5.97e-05	0.00024	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—multiple sclerosis	5.96e-05	0.00024	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—multiple sclerosis	5.93e-05	0.000238	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—multiple sclerosis	5.71e-05	0.00023	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—multiple sclerosis	5.64e-05	0.000227	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TYK2—multiple sclerosis	5.6e-05	0.000225	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—multiple sclerosis	5.55e-05	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—multiple sclerosis	5.53e-05	0.000222	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.47e-05	0.00022	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK1—multiple sclerosis	5.43e-05	0.000218	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—multiple sclerosis	5.42e-05	0.000218	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—multiple sclerosis	5.08e-05	0.000204	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—multiple sclerosis	5.04e-05	0.000202	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—multiple sclerosis	5.02e-05	0.000202	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—multiple sclerosis	5.02e-05	0.000202	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK1—multiple sclerosis	4.93e-05	0.000198	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—multiple sclerosis	4.72e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—multiple sclerosis	4.7e-05	0.000189	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.69e-05	0.000189	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—multiple sclerosis	4.66e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—multiple sclerosis	4.66e-05	0.000187	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—multiple sclerosis	4.65e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—multiple sclerosis	4.63e-05	0.000186	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK1—multiple sclerosis	4.61e-05	0.000185	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK1—multiple sclerosis	4.56e-05	0.000183	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—multiple sclerosis	4.41e-05	0.000177	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.28e-05	0.000172	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—multiple sclerosis	4.17e-05	0.000168	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BCHE—multiple sclerosis	4.05e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—multiple sclerosis	3.92e-05	0.000158	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—multiple sclerosis	3.79e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—multiple sclerosis	3.64e-05	0.000146	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—multiple sclerosis	3.63e-05	0.000146	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK1—multiple sclerosis	3.56e-05	0.000143	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—multiple sclerosis	3.55e-05	0.000143	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—multiple sclerosis	3.5e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—multiple sclerosis	2.74e-05	0.00011	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOE—multiple sclerosis	2.43e-05	9.79e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POMC—multiple sclerosis	2.09e-05	8.41e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—multiple sclerosis	1.91e-05	7.66e-05	CbGpPWpGaD
